Fermenta Biotech Ltd — Important, 28-05-2026: Company Update

Fermenta Biotech has shared its Q4 and full-year FY26 earnings presentation. The company's full-year consolidated revenue grew 14% to INR 547.8 crore, with core revenue (excluding real estate) up 27% to INR 546 crore. Profit after tax for FY26 stood at INR 70.3 crore. Key growth drivers included Vitamin D3 Human Nutrition, up 28% to INR 293 crore, and Animal Nutrition, up 32% to INR 109 crore. Green Chemistry sales more than doubled. The company reported a strong balance sheet with free cash flow tripling to INR 62 crore and debt-to-equity improving to 0.27.